John M Pawelek

Dr. John M Pawelek

Yale Cancer Center, New Haven, CT, USA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2008 in Nature Reviews Cancer
Verified
Journal Article
Closed access
John M PawelekJohn M Pawelek
John M Pawelek
ACAshok K. Chakraborty
Ashok K. Chakraborty

15 January 2012 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
RLRossitza Lazova
Rossitza Lazova
RCRobert L. Camp
Robert L. Camp
VKVincent Klump
Vincent Klump
SSSummar F. Siddiqui
Summar F. Siddiqui
RARavi K. Amaravadi
Ravi K. Amaravadi
John M PawelekJohn M Pawelek
John M Pawelek
Purpose: Measurement of autophagy in cancer and correlation with histopathologic grading or clinical outcomes has been limited. Accordingly, we investigated LC3B as an autophagosome marker by analyzing nearly 1,400 tumors from 20 types of cancer, focusing on correlations with clinical outcomes in melanoma and breast cancer. Experimental Design: Staining protocols were developed for automated quantitative analysis (AQUA) using antibodies versus LC3 isoform B (LC3B) and Ki-67. Clinically annotated breast and melanoma tissue microarrays (TMA) and a multitumor array were used. An AQUA program was developed to quantitate LC3B distribution in punctate and diffuse compartments of the cell. Results: LC3B staining was moderate to high in the large majority of tumors. The percentage of area occupied by punctate LC3B was elevated by 3- to 5-fold at high LC3B intensities. In breast cancer and melanoma TMAs, LC3B and Ki-67 showed strong correlations (P < 0.0001), and in multitumor TMAs, mitotic figures were most often seen in tumors with the highest LC3B expression (P < 0.002). In breast cancer, LC3B expression was elevated in node-positive versus node-negative primaries and associated with increased nuclear grade and shortened survival. In a melanoma TMA with no survival data, LC3B levels were highest in nodal, visceral, and cutaneous metastases. Conclusions: The results reveal a common expression of LC3B in malignancy and support emerging evidence that autophagy plays a significant role in cancer progression. High LC3B was associated proliferation, invasion and metastasis, high nuclear grade, and worse outcome. Thus, autophagy presents a key target of therapeutic vulnerability in solid tumors. Clin Cancer Res; 18(2); 370–9. ©2011 AACR.

1 September 2003 in The Lancet Oncology
Verified
Journal Article
Closed access
John M PawelekJohn M Pawelek
John M Pawelek
KLK Brooks Low
K Brooks Low
David BermudesDavid Bermudes
David Bermudes

1 December 2005 in The Lancet Oncology
Verified
Journal Article
Closed access
John M PawelekJohn M Pawelek
John M Pawelek

16 December 2009 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
PDF file
RLRossitza Lazova
Rossitza Lazova
VKVincent Klump
Vincent Klump
John M PawelekJohn M Pawelek
John M Pawelek

26 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RLRossitza Lazova
Rossitza Lazova
GLGreggory S. LaBerge
Greggory S. LaBerge
EDEric Duvall
Eric Duvall
NSNicole Spoelstra
Nicole Spoelstra
VKVincent Klump
Vincent Klump
John M PawelekJohn M Pawelek
John M Pawelek
Tumor cell fusion with motile bone marrow-derived cells (BMDCs) has long been posited as a mechanism for cancer metastasis. While there is much support for this from cell culture and animal studies, it has yet to be confirmed in human cancer, as tumor and marrow-derived cells from the same patient cannot be easily distinguished genetically. We carried out genotyping of a metastatic melanoma to the brain that arose following allogeneic bone-marrow transplantation (BMT), using forensic short tandem repeat (STR) length-polymorphisms to distinguish donor and patient genomes. Tumor cells were isolated free of leucocytes by laser microdissection, and tumor and pre-transplant blood lymphocyte DNAs were analyzed for donor and patient alleles at 14 autosomal STR loci and the sex chromosomes. All alleles in the donor and patient pre-BMT lymphocytes were found in tumor cells. The alleles showed disproportionate relative abundances in similar patterns throughout the tumor, indicating the tumor was initiated by a clonal fusion event. Our results strongly support fusion between a BMDC and a tumor cell playing a role in the origin of this metastasis. Depending on the frequency of such events, the findings could have important implications for understanding the generation of metastases, including the origins of tumor initiating cells and the cancer epigenome.